Skip to main content
CIBINQO 200 mg/1 tablet, film coated by U.S. Pharmaceuticals
CIBINQO, 200 mg/1, tablet, film coated Drug class: Janus Kinase Inhibitor. Available on prescription only. Listed by U.S. Pharmaceuticals.
Prescription only

CIBINQO

abrocitinib

Listed by U.S. Pharmaceuticals

Strength
200 mg/1
Form
Tablet, Film Coated
Route
Oral
Class
Janus Kinase Inhibitor

What it contains

  • Abrocitinib 200 mg/1

FDA record

Dosage form Tablet, Film Coated
Route Oral
Drug class Janus Kinase Inhibitor
Approval route NDA — original brand approval
NDC code 63539-436
FDA application NDA213871
RxNorm concept 2591481
Package sizes listed 1
Marketed since February 2022

Other products containing Abrocitinib

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

CIBINQO

abrocitinib

Strength
100 mg/1
Form
Tablet, Film Coated
Class
Janus Kinase Inhibitor
Rx only

U.S. Pharmaceuticals

Not stocked by us — reference only

Cibinqo

abrocitinib

Strength
200 mg/1
Form
Tablet, Film Coated
Class
Janus Kinase Inhibitor
Rx only

Pfizer Laboratories Div Pfizer Inc

Not stocked by us — reference only

Cibinqo

abrocitinib

Strength
50 mg/1
Form
Tablet, Film Coated
Class
Janus Kinase Inhibitor
Rx only

Pfizer Laboratories Div Pfizer Inc

Not stocked by us — reference only

CIBINQO

abrocitinib

Strength
50 mg/1
Form
Tablet, Film Coated
Class
Janus Kinase Inhibitor
Rx only

U.S. Pharmaceuticals

Not stocked by us — reference only

Cibinqo

abrocitinib

Strength
100 mg/1
Form
Tablet, Film Coated
Class
Janus Kinase Inhibitor
Rx only

Pfizer Laboratories Div Pfizer Inc

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.